Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 5, 2003, Pages 403-404

  Vanier, Kelly L ^a   Mattiussi, Andrea J ^b   Johnston, Donna L ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

All trans retinoic acid; Drug interactions; Fluconazole

Indexed keywords

CYTARABINE; CYTOCHROME P450; DAUNORUBICIN; FLUCONAZOLE; MEROPENEM; RETINOIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN PSEUDOTUMOR; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG TOLERABILITY; ENZYME INHIBITION; FEBRILE NEUTROPENIA; HEADACHE; HUMAN; HUMAN TISSUE; LIVER METABOLISM; MALE; MYCOSIS; PAPILLEDEMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TOXICITY; VOMITING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; FEMALE; FLUCONAZOLE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; TRETINOIN;

EID: 0038559875     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200305000-00010     Document Type: Article

References (13)

1. Golub TR, Arceci RJ. Acute myelogenous leukemia. In Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins. 2002:553.
2. De The H, Chomienne C, Lanotte M, et al. The t(15:17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990;347:558-61.
3. Schroeter T. Lanvers C. Herding H, et al. Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia, Med Pediatr Oncol 2000;34:284-86.
4. Visani G, Manfroi S, Tosi P, et al. All-trans-retinoic acid and pseudotumor cerebri. Leuk Lymphoma 1996;23:437-42.
5. , Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994;83:10-25.
6. Smith M, Adamson P, Balis F, et al. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer. J Clin Oncol 1992;10: 1666-73.
7. Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology 1984;34:1509-11.
8. Schwarts EL, Hallam S, Gallagher RE, et al. Inhibition of all-trans retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Biochem Pharmacol 1995;50:923-28.
9. Rigas JR, Francis PA, Muindi JR, et al. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole, J Natl Cancer Inst 1993;85:1921-6.
10. Sano F, Tsuji K, Kunika N, et al. Pseudotumor cerebri in a patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Intern Med 1998;37:546-9.
11. McSorley L, Daly A. Identification of human cytochrome P-450 isoforms that contribute to ATRA 4-hydroxylation. Biochem Pharmacol 2000;60:517-26.
12. Nadin L, Murray M. Participation of CYP 2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes. Biochem Pharmacol 1999;58:1201-8.
13. Gupta A, Katz H, Shear N. Drug interactions with itraconazole, fluconazole and terbinafine and their management. J Am Acad Dermatol 1999;41:237-49.